Autogenic training to manage symptomology in women with chest pain and normal coronary arteries

Menopause

Volumn 16, Issue 1, 2009, Pages 60-65

  Asbury, Elizabeth A ^a   Kanji, Nasim ^b   Ernst, Edzard ^c   Barbir, Mahmoud ^d   Collins, Peter ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b BUCKINGHAMSHIRE NEW UNIVERSITY   (United Kingdom)

^c PENINSULA MEDICAL SCHOOL   (United Kingdom)

^d HAREFIELD HOSPITAL   (United Kingdom)

Author keywords

Autogenic training; Chest pain; Psychology; Quality of life; Relaxation

Indexed keywords

CATECHOLAMINE;

ADULT; AGED; ARTICLE; AUTOGENIC TRAINING; BLOOD PRESSURE; CATECHOLAMINE BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY; DISEASE MARKER; DISEASE SEVERITY; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; FERRANS AND POWERS QUALITY OF LIFE INDEX; HEART MUSCLE ISCHEMIA; HEART RATE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MORBIDITY; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; STATE TRAIT ANXIETY INVENTORY; STRESS; STRUCTURED QUESTIONNAIRE; SYMPTOMATOLOGY; SYNDROME X; THORAX PAIN; ANXIETY; BLOOD; CORONARY BLOOD VESSEL; DEPRESSION; MIDDLE AGED; PATHOPHYSIOLOGY;

AGED; ANXIETY; AUTOGENIC TRAINING; BLOOD PRESSURE; CATECHOLAMINES; CHEST PAIN; CORONARY VESSELS; DEPRESSION; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; HEART RATE; HUMANS; MICROVASCULAR ANGINA; MIDDLE AGED; MYOCARDIAL ISCHEMIA; QUALITY OF LIFE;

EID: 64049105433     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e318184762e     Document Type: Article

References (39)

1. Likoff W, Segal BL, Kasparian H. Paradox of normal selective coronary arteriograms in patients considered to have unmistakable coronary heart disease. N Engl J Med 1967;276:1063-1066.
2. Kemp HG Jr. Left ventricular function in patients with the anginal syndrome and normal coronary arteriograms. Am J Cardiol 1973;32:375-376.
3. Cannon RO III, Epstein SE. "Microvascular angina" as a cause of chest pain with angiographically normal coronary arteries. Am J Cardiol 1988;61:1338-1343.
4. Kaski JC, Cox ID, Crook JR, et al. Differential plasma endothelin levels in subgroups of patients with angina and angiographically normal coronary arteries. Coronary Artery Disease Research Group. Am Heart J 1998;136:412-417.
5. Lanza GA. Cardiac syndrome X: a critical overview and future perspectives. Heart 2007;93:159-166.
6. Panting JR, Gatehouse PD, Yang GZ, et al. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med 2002;346:1948-1953.
7. Kaski JC. Cardiac syndrome X in women: the role of oestrogen deficiency. Heart 2006;92(Suppl 3):iii5-iii9.
8. Rosen SD, Paulesu E, Wise RJ, Camici PG. Central neural contribution to the perception of chest pain in cardiac syndrome X. Heart 2002;87:513-519.
9. Cannon RO III, Quyyumi AA, Schenke WH, et al. Abnormal cardiac sensitivity in patients with chest pain and normal coronary arteries. J Am Coll Cardiol 1990;16:1359-1366.
10. Zubieta JK, Smith YR, Bueller JA, et al. K-Opioid receptor-mediated antinociceptive responses differ in men and women. J Neurosci 2002;22:5100-5107.
11. Ozcelik F, Altun A, Ozbay G. Antianginal and anti-ischemic effects of nisoldipine and ramipril in patients with syndrome X. Clin Cardiol 1999;22:361-365.
12. Radice M, Giudici V, Albertini A, Mannarini A. Usefulness of changes in exercise tolerance induced by nitroglycerin in identifying patients with syndrome X. Am Heart J 1994;127:531-535.
13. Cannon RO III, Quyyumi AA, Mincemoyer R, et al. Imipramine in patients with chest pain despite normal coronary angiograms. N Engl J Med 1994;330:1411-1417.
14. Adamson DL, Webb CM, Collins P. Esterified estrogens combined with methyltestosterone improve emotional well-being in postmenopausal women with chest pain and normal coronary angiograms. Menopause 2001;8:233-238.
15. Rosano GM, Peters NS, Lefroy D, et al. 17-β-Estradiol therapy lessens angina in postmenopausal women with syndrome X. J Am Coll Cardiol 1996;28:1500-1505.
16. Jessurun GA, Hautvast RW, Tio RA, DeJongste MJ. Electrical neuromodulation improves myocardial perfusion and ameliorates refractory angina pectoris in patients with syndrome X: fad or future? Eur J Pain 2003;7:507-512.
17. Sgueglia GA, Sestito A, Spinelli A, et al. Long-term follow-up of cardiac syndrome X patients treated by spinal cord stimulation. Heart 2007;95:591-597.
18. Asbury EA, Creed F, Collins P. Distinct psychosocial differences between women with coronary heart disease and cardiac syndrome X. Eur Heart J 2004;25:1695-1701.
19. Cunningham C, Brown S, Kaski JC. Effects of transcendental meditation on symptoms and electrocardiographic changes in patients with cardiac syndrome X. Am J Cardiol 2000;85:653-655, A10.
20. Jones H, Cooper P, Miller V, Brooks N, Whorwell PJ. Treatment of non-cardiac chest pain: a controlled trial of hypnotherapy. Gut 2006;55:1403-1408.
21. Tyni-Lenne R, Stryjan S, Eriksson B, Berglund M, Sylven C. Beneficial therapeutic effects of physical training and relaxation therapy in women with coronary syndrome X. Physiother Res Int 2002;7:35-43.
22. Kanji N. Autogenic training. Complement Ther Med 1997;5:162-167.
23. Kanji N, White AR, Ernst E. Autogenic training reduces anxiety after coronary angioplasty: a randomized clinical trial. Am Heart J 2004;147:E10.
24. Sutherland G, Andersen MB, Morris T. Relaxation and health-related quality of life in multiple sclerosis: the example of autogenic training. J Behav Med 2005;28:249-256.
25. Hidderley M, Holt M. A pilot randomized trial assessing the effects of autogenic training in early stage cancer patients in relation to psychological status and immune system responses. Eur J Oncol Nurs 2004;8:61-65.
26. Kanji N. Management of pain through autogenic training. Complement Ther Nurs Midwifery 2000;6:143-148.
27. Zamarra JW, Schneider RH, Besseghini I, Robinson DK, Salerno JW. Usefulness of the transcendental meditation program in the treatment of patients with coronary artery disease. Am J Cardiol 1996;77:867-870.
28. Infante JR, Torres-Avisbal M, Pinel P, et al. Catecholamine levels in practitioners of the transcendental meditation technique. Physiol Behav 2001;72:141-146.
29. Spielberger C, Gorsuch R, Lushene R, Vagg P, Jacobs G. Manual for State-Trait Anxiety Inventory, Self Evaluation Questionnaire. Palo Alto, CA: Consulting Psychologist Press Inc, 1980.
30. Eifert GH, Thompson RN, Zvolensky MJ, et al. The Cardiac Anxiety Questionnaire: development and preliminary validity. Behav Res Ther 2000;38:1039-1053.
31. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983;67:361-370.
32. Ferrans S, Powers M. Quality of Life Index: development and psychometric properties. Res Nurs Health 1985;15:29-38.
33. Altman D. Practical Statistics for Medical Research. London, UK: Chapman & Hall, 1991.
34. Jensen M, Patterson DR. Hypnotic treatment of chronic pain. J Behav Med 2006;29:95-124.
35. Bujatti M, Riederer P. Serotonin, noradrenaline, dopamine metabolites in transcendental meditation-technique. J Neural Transm 1976;39:257-267.
36. Zouridakis EG, Cox ID, Garcia-Moll X, Brown S, Nihoyannopoulos P, Kaski JC. Negative stress echocardiographic responses in normotensive and hypertensive patients with angina pectoris, positive exercise stress testing, and normal coronary arteriograms. Heart 2000;83:141-146.
37. Rosen SD, Boyd H, Rhodes CG, Kaski JC, Camici PG. Myocardial beta-adrenoceptor density and plasma catecholamines in syndrome X. Am J Cardiol 1996;78:37-42.
38. Asbury EA, Slattery C, Grant A, Evans L, Barbir M, Collins P. Cardiac rehabilitation for the treatment of women with chest pain and normal coronary arteries. Menopause 2008;15:454-460.
39. Klimes I, Mayou RA, Pearce MJ, Coles L, Fagg JR. Psychological treatment for atypical non-cardiac chest pain: a controlled evaluation. Psychol Med 1990;20:605-611.